Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Neuroblastoma is a cancer that arises in immature nerve cells and affects mostly infants and children. Abnormal nerve cells may be present before birth, but the diagnosis isn’t made until the cells begin to multiply, forming a tumor. Neuroblastoma is most commonly diagnosed in children less than 5 years of age and is very rare after the age of 10. A neuroblastoma tumor usually begins in the abdomen, especially in the tissues of the adrenal glands, which sit on top of the kidneys but also may begin in nerve tissue in the neck, chest or pelvis.
Children with neuroblastoma are treated through the Neuroblastoma Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Because neuroblastoma is rarely seen in adults, it is important that your child receive care from an experienced team of pediatric specialists who focus exclusively on treating childhood cancers. Our neuroblastoma specialists and surgeons are known for treating children with the most complex cases (including relapsed or refractory neuroblastoma), as well as for their expertise in delivering specialized treatments, including MIBG therapy and stem cell transplantation.
Find in-depth information on neuroblastoma on the Dana-Farber/Boston Children's website, including details on neuroblastoma symptoms, diagnosis and treatment.
Appointments and Second Opinions